SBRA at a glance
Sabra Health Care REIT, Inc. (SBRA, SEC CIK 1492298) filed its latest 10-K annual report on February 12, 2026, a 10-Q quarterly report on November 2, 2026, an 8-K current report on November 2, 2026 and Form 4 insider filings as recently as November 12, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.
- For the fiscal year ended December 31, 2025 (FY2025), Sabra Health Care REIT, Inc. (SBRA) reported revenue of $356.9 million (up 25.4% from FY2024) and net income of $155.6 million. Diluted EPS was $0.64.
- As of September 30, 2026, 33 institutional investment managers tracked by SignalX reported holding Sabra Health Care REIT, Inc. (SBRA) shares worth $3.0 billion in 13F-HR filings.
- The most recent insider open-market sale reported on Form 4 was by FOSTER MICHAEL J on November 11, 2026 of 10,000 shares at $20.98 per share.
- In the last 90 days, SBRA insiders reported 0 open-market purchases ($0) and 2 open-market sales ($4.4M) on Form 4, a net sale of $4.4M.
Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).
- Revenue · FY2025
- $356.9M
- +25.4% vs prior year
- Insiders · 90 days
- 0 buys · 2 sells
- Net −$4.4M
- 13F holders
- 33 funds
- $3.0B · −1 vs prior quarter
- Latest 8-K
- Nov 2, 2026
- Item 7.01 · Item 2.02
AI 10-K Annual Report Analysis
Latest 10-K, fiscal year ended Dec 31, 2025
Business Overview
- Core business model: Real estate investment trust focusing on healthcare properties with skilled nursing, senior housing, and specialty hospitals
- Emphasis on occupancy trends with skilled nursing occupancy increasing to 83.4% in 2025 from 76.4% in 2023
- Senior Housing - Leased occupancy stable near 89%, while Behavioral Health occupancy declined to 76.5% in 2025 from 80.7% in 2023
- Facility financial data derived solely from tenants/operators, no independent verification by Sabra
- Occupancy data used cautiously, excluding non-stabilized properties and reflecting only facilities owned at each period end
Risk Factors
- Regulatory risk: heightened enforcement of Medicare and Medicaid rules increasing inspections, citations, and penalties affecting tenants' operations and reimbursement
- Macroeconomic threat: inflation increasing operating and capital expenses faster than rental income, pressuring profitability of Senior Housing - Managed communities
- Supply chain vulnerability: labor shortages and wage inflation forcing tenants and operators to raise pay or use costly contract staff, impacting cash flows
- Competitive risk: competition from larger REITs, private equity, hedge funds, and alternatives like home health services reducing occupancy and rents
- Financial risk: dependency on CEO Mr. Matros, loss of whom could impair management and strategic execution
Management Discussion & Analysis
- Revenue $774.6M in 2025, up 8% YoY from $703.1M; rental revenues down $7.4M, resident fees up $72.3M, interest income up $6.5M
- Operating margin not explicitly stated; depreciation up 10% to $187.0M, interest expense down 2% to $112.5M, senior housing operating expenses up 22% to $256.6M
- Best segment: Senior Housing - Managed revenue $356.9M, +25% YoY; Worst segment: triple-net rental revenues $374.1M, -2% YoY
- Net cash provided by operating activities $348.6M; investing cash outflows $378.0M for acquisitions and additions; financing cash inflows $40.8M including $500M term loan proceeds; dividends paid $289.5M
- $1.2B liquidity as of Dec 31, 2025 including $71.5M cash and $782.4M available revolver; management expects sufficient cash flow and credit availability for next 12 months; redeemed $500M 2026 notes in July 2025
AI summary of the SBRA 10-K filed . Generated from the filing text; verify against the original.View on SEC EDGARHow to read a 10-K
AI 10-Q Quarterly Report Analysis
Latest 10-Q, quarter ended Sep 30, 2026
Management Discussion & Analysis
- Quarterly revenue $249.6M vs $190.0M YoY, up $59.5M, led by resident fees and services
- AFFO margin 46.7% vs 47.7% YoY, with AFFO $116.6M vs $90.7M
- Best line: resident fees and services $143.2M, up $51.1M; worst: interest income $3.2M, down $9.4M
- Liquidity $1.2B, operating cash flow $313.2M, acquisitions $516.3M, dividends paid $228.0M
- Headwinds: inflation, higher operating costs, capital constraints, tenant and borrower credit risk; Medicare rates up 2.4% for fiscal 2027
Risk Factors
- No new or changed risk factors identified, with risks carried forward from the 2025 10-K
- Regulatory risk: healthcare regulation and enforcement could disrupt tenant operations and reimbursement
- Operational risk: SHOP operating expenses rose to $269.8 million from $179.8 million
- Financial risk: Revolving Credit Facility matures January 4, 2027, with $126.5 million outstanding
- Credit risk: Recovery Centers of America mortgage payoff reduced to $200.0 million from $300.0 million, creating a $100.0 million write-off
AI summary of the SBRA 10-Q filed . Generated from the filing text; verify against the original.View on SEC EDGAR10-K vs 10-Q vs 8-K
AI 8-K Current Report Analysis
The most recent material events, by 8-K item
Item 7.01: Regulation FD Disclosure
- Supplemental information package available in Exhibit 99.2 and on Sabra’s investor website
- Exhibit 99.1 press release and Exhibit 99.4 presentation materials provide the substantive investor information
Item 2.02: Results of Operations and Financial Condition
- Third-quarter 2026 operating results released for the period ended September 30, 2026
- Press release and non-GAAP reconciliations available in Exhibits 99.1 and 99.3
Item EX-99.3: Item EX-99.3
- 2026 guidance: Normalized FFO $1.540-$1.550 per share and Normalized AFFO $1.600-$1.610
- Guidance assumes low-single-digit triple-net Cash NOI growth and mid-teens same-store SHOP Cash NOI growth
Item EX-99.1: Item EX-99.1
- Q3 Normalized FFO $0.39 and Normalized AFFO $0.41 per share, supporting the $0.30 quarterly dividend
- Same-property SHOP Cash NOI increased 14.6% year over year, reinforcing Sabra’s shift toward higher-growth operating assets
Item EX-99.2: Item EX-99.2
- Q3 2026 revenues $249.6M, up from $190.0M, driven by resident fees and services of $143.2M
- Normalized AFFO $0.41 per diluted share versus $0.30 dividend, implying quarterly payout coverage of approximately 1.4x
Item EX-99.4: Item EX-99.4
- 2026 guidance midpoint implies Normalized FFO $1.545 per share, approximately 7% year-over-year growth
- Year-to-date investments nearly $750M, approximately 80% SHOP, at estimated 8.0% yield
Item EX-99.32: Item EX-99.32
- 2026 normalized FFO guidance $1.53-$1.55 per share, normalized AFFO $1.59-$1.61
- Guidance assumes low-single-digit triple-net Cash NOI growth and low-to-mid-teens same-store managed-housing Cash NOI growth
Item EX-99.42: Item EX-99.42
- 2026 guidance reiterated: normalized FFO $1.53-$1.55 and normalized AFFO $1.59-$1.61 per diluted share
- Guidance midpoint implies approximately 7% normalized FFO and 8% normalized AFFO year-over-year growth
Item EX-99.12: Item EX-99.12
- Q2 normalized FFO $0.38 and normalized AFFO $0.40 per share, supporting the $0.30 quarterly dividend
- GAAP net loss $(0.10) per share, driven by a $102.4 million provision for loan losses and other reserves
Item EX-99.22: Item EX-99.22
- Q2 2026 revenue $235.9M, up from $189.2M, driven by managed senior housing expansion
- Net loss $25.2M, reflecting $102.4M provision for loan losses and other reserves
Item 2.02: Results of Operations and Financial Condition
- Sabra reported second-quarter 2026 results for the three months ended June 30, 2026
- Press release furnished as Exhibit 99.1, with non-GAAP reconciliations in Exhibit 99.3
Item 7.01: Regulation FD Disclosure
- Supplemental information package furnished as Exhibit 99.2 and available on Sabra’s investor website
- Exhibit 99.4 presentation materials intended for investor presentations
Item EX-99.1: Item EX-99.1
- Q2 normalized FFO $0.38 and normalized AFFO $0.40 per share, supporting the $0.30 quarterly dividend
- GAAP net loss $(0.10) per share, driven by a $102.4M provision for loan losses and other reserves
Item 7.01: Regulation FD Disclosure
- Sabra issued a press release as Exhibit 99.1 under Regulation FD
- Investors should review Exhibit 99.1 for the substantive disclosure and potential market impact
AI summaries of SBRA 8-K current reports filed with the SEC. What 8-K item codes mean
SignalX for SBRA
Don't miss the next SBRA filing
- Alerts as it files. A push when SBRA files an 8-K or an insider trades.
- Fund moves. Which tracked funds opened, added or cut SBRA, by share count.
- Ask anything. An AI agent that reads every SBRA filing and answers with sources.
Recent Insider Transactions (Form 4)
Latest reported trades by officers, directors and 10% owners
| Insider | Type | Date | Shares | Price |
|---|---|---|---|---|
| FOSTER MICHAEL J | Sell | Nov 11, 2026 | 10,000 | $20.98 |
| MATROS RICHARD K | Sell | Sep 8, 2026 | 200,000 | $20.83 |
| Cusack Catherine | A | Aug 31, 2026 | 791 | - |
| Malehorn Jeffrey A. | A | Aug 31, 2026 | 791 | - |
| Smith Darrin | A | Aug 31, 2026 | 495 | - |
| FLORES JESSICA | A | Aug 31, 2026 | 382 | - |
| Kono Ann | A | Aug 31, 2026 | 791 | - |
| Costa Michael Lourenco | A | Aug 31, 2026 | 4,158 | - |
Financial SummaryXBRL
| Metric | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|
| Profitability | ||||
| Revenue | $236.2M | $284.6M | $356.9M | |
| Net Income | $13.8M | $126.7M | $155.6M | |
| Net Margin | 5.8% | 44.5% | 43.6% | |
| Balance Sheet | ||||
| Total Assets | $5.4B | $5.3B | $5.5B | |
| Equity | $2.8B | $2.7B | $2.8B | |
| ROE | 0.5% | 4.6% | 5.5% | |
| Per Share | ||||
| EPS | $0.06 | $0.54 | $0.64 | |
| Cash Flow | ||||
| Operating CF | $300.6M | $310.5M | $348.6M | |
Source: XBRL data in Sabra Health Care REIT, Inc. (SBRA)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →
13F Fund Holdings: Quarterly Trend
Latest: Q3 2026Aggregate SBRA share value held by 13F filers tracked by SignalX, by quarter.
Quarterly totals table
| Quarter | Funds | Total value |
|---|---|---|
| Q3 2026 | 33 | $3.00B |
| Q2 2026 | 34 | $3.01B |
| Q1 2026 | 34 | $3.02B |
| Q4 2025 | 32 | $2.81B |
| Q3 2025 | 32 | $2.71B |
| Q2 2025 | 30 | $2.58B |
| Q1 2025 | 29 | $1.80B |
| Q4 2024 | 25 | $1.57B |
- AQR Capital Management+2.77M (+139%)
- Two Sigma Investments+1.93M (+99%)
- BlackRock+980.1K (+2%)
- State Street Corp+299.9K (+2%)
- Citadel Advisors LLC+221.8K (+42%)
- Invesco Ltd−1.40M (-55%)
- JPMorgan Chase & Co−1.17M (-36%)
- Principal Financial Group−869.7K (-4%)
- Millennium Management−665.9K (-89%)
- Goldman Sachs Group−656.6K (-19%)
- Renaissance Technologies LLC+138.0K
- FMR LLC (Fidelity)−2.96M
- COHEN & STEERS, INC.−103.5K
Source: 13F-HR filings on SEC EDGAR (aggregated from 249 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work
SBRA filing archive
AI analysis pages for each 10-K, 10-Q and 8-K
10-K annual reports
10-Q quarterly reports
Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4
| Form | Filing date | Period | Analysis | SEC |
|---|---|---|---|---|
| 4 | Nov 12, 2026 | - | - | - |
| 10-Q | Nov 2, 2026 | Sep 30, 2026 | Analysis | |
| 8-K | Nov 2, 2026 | - | Analysis | - |
| 4 | Sep 9, 2026 | - | - | - |
| 4 | Sep 2, 2026 | - | - | - |
| 4 | Sep 2, 2026 | - | - | - |
| 4 | Sep 2, 2026 | - | - | - |
| 4 | Sep 2, 2026 | - | - | - |
| 4 | Sep 2, 2026 | - | - | - |
| 4 | Sep 2, 2026 | - | - | - |
| 4 | Sep 2, 2026 | - | - | - |
| 4 | Sep 2, 2026 | - | - | - |
| 4 | Sep 2, 2026 | - | - | - |
| 4 | Sep 2, 2026 | - | - | - |
| 10-Q | Aug 3, 2026 | Jun 30, 2026 | Analysis | |
| 8-K | Aug 3, 2026 | - | Analysis | - |
| 8-K | Jul 21, 2026 | - | Analysis | - |
| 4 | Jun 18, 2026 | - | - | - |
| 4 | Jun 18, 2026 | - | - | - |
| 4 | Jun 18, 2026 | - | - | - |
| 4 | Jun 18, 2026 | - | - | - |
| 4 | Jun 18, 2026 | - | - | - |
| 4 | Jun 18, 2026 | - | - | - |
| 8-K | Jun 17, 2026 | - | Analysis | - |
| 4 | Jun 2, 2026 | - | - |
Related Real Estate companies
- AKR · ACADIA REALTY TRUSTReal Estate Investment Trusts
- ACR · ACRES Commercial Realty Corp.Real Estate Investment Trusts
- ADAM · ADAMAS TRUST, INC.Real Estate Investment Trusts
- ALX · ALEXANDERS INCReal Estate Investment Trusts
- ARE · Alexandria Real Estate EquitiesReal Estate Investment Trusts
- PINE · Alpine Income Property Trust, Inc.Real Estate Investment Trusts
- AAT · American Assets Trust, Inc.Real Estate Investment Trusts
- AHR · American Healthcare REIT, Inc.Real Estate Investment Trusts
SBRA SEC filings: frequently asked questions
Are SBRA insiders buying or selling?
In the last 90 days, Sabra Health Care REIT, Inc. (SBRA) officers, directors and 10% owners reported no open-market purchases and 2 open-market sales worth $4.4 million by 2 insiders on Form 4. Many insider sales are pre-planned or for taxes, so purchases usually carry more information.
Which institutions hold SBRA stock?
As of September 30, 2026, the largest Sabra Health Care REIT, Inc. (SBRA) holders among the 13F filers tracked by SignalX were BlackRock ($840.0 million), Principal Financial Group ($470.1 million), Vanguard Portfolio Management LLC ($461.5 million), State Street Corp ($248.6 million), Vanguard Capital Management LLC ($224.6 million). 13F-HR reports are filed up to 45 days after each quarter ends.
What was SBRA's revenue in fiscal year 2025?
For the fiscal year ended December 31, 2025 (FY2025), Sabra Health Care REIT, Inc. (SBRA) reported revenue of $356.9 million (up 25.4% from FY2024) and net income of $155.6 million. Diluted EPS was $0.64. The figures come from the XBRL data in the 10-K.
What are the main risks in SBRA's latest 10-K?
In the 10-K filed February 12, 2026, Sabra Health Care REIT, Inc. (SBRA) flagged: Regulatory risk: heightened enforcement of Medicare and Medicaid rules increasing inspections, citations, and penalties affecting tenants' operations and reimbursement. Macroeconomic threat: inflation increasing operating and capital expenses faster than rental income, pressuring profitability of Senior Housing - Managed communities. (AI summary of the Risk Factors section.)
What did SBRA report in its latest 8-K?
Sabra Health Care REIT, Inc. (SBRA) filed an 8-K on November 2, 2026 reporting Item 7.01 (Regulation FD Disclosure) and Item 2.02 (Results of Operations and Financial Condition). Supplemental information package available in Exhibit 99.2 and on Sabra’s investor website.
What are the latest SBRA SEC filings?
Sabra Health Care REIT, Inc. (SBRA) filed its latest 10-K annual report on February 12, 2026, a 10-Q quarterly report on November 2, 2026, an 8-K current report on November 2, 2026 and a Form 4 insider filing on November 12, 2026.
What is SBRA's SEC CIK number?
Sabra Health Care REIT, Inc. (SBRA)'s SEC Central Index Key (CIK) is 1492298. EDGAR lists every SBRA filing under that number.
Ask anything about SBRA
The research agent reads SBRA's filings, financials, insider trades and 13F holders, then answers with sources.